drugset / Trial / NCT01580618
Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of the study is to determine the safety and efficacy of TNK infusion for the treatment of loculated pleural effusions in patients with known malignancy compared to normal saline infusion.
Timeline
- Start
- 2008-01
- Primary completion
- 2011-09
- Completion
- 2011-09
Outcome
Outcome not reported
Stopped (Enrollment): “Unable to accrue patients at a reasonable rate”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tenecteplase | Protein / enzyme biologic | 4 mg | Other |
Indications
No indication recorded.